Neural Stem Cells from Shank3-ko Mouse Model Autism Spectrum Disorders

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Autism spectrum disorders (ASD) are neurodevelopmental conditions linked to genetic factors, impacting social communication and behavior.
• Early neuronal degeneration mechanisms in ASD remain unclear, hindering effective therapeutic strategies.

Purpose of the Study:

• To investigate the neurogenic potential of neural stem cells (NSCs) from an ASD animal model.
• To determine if Shank3 gene mutations affect NSC properties and recapitulate early neurogenesis phases in ASD.

Main Methods:

• Isolation and in vitro culture of NSCs from the subventricular zone (SVZ) of Shank3-deficient (Shank3-ko) and wild-type (wt) mice.
• Assessment of NSC self-renewal, differentiation, glial cell pathology (endosomal/lysosomal and ubiquitin aggregation), mitochondrial function, and inflammasome activation.

Main Results:

• Shank3-ko NSCs maintained self-renewal but exhibited accelerated differentiation compared to wt cells.
• Glial cells in Shank3-ko models showed lysosomal/endosomal aggregation, mitochondrial dysfunction, and inflammasome activation.
• In vitro findings align with in vivo data from ASD patients, suggesting Shank3 deficiency impacts later neurogenesis or cell survival.

Conclusions:

• Shank3-ko NSCs provide a valid in vitro model for studying ASD neurogenesis.
• Glial cell degeneration appears to contribute significantly to neuronal damage in ASD.
• Therapeutic strategies targeting glial cell rescue may prevent neuronal degeneration in ASD.